| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... MedRxiv, 2021.06. 15.21258542, 2021 | 1440* | 2021 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 402 | 2021 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 321 | 2021 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 236 | 2022 |
| Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group The Lancet Respiratory Medicine 9 (12), 1419-1426, 2021 | 145 | 2021 |
| Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10289), 2049-2059, 2021 | 113 | 2021 |
| Diagnosis and management of cerebral venous thrombosis R Behrouzi, M Punter Clinical Medicine 18 (1), 75-79, 2018 | 112 | 2018 |
| HE4 as a Biomarker for Endometrial Cancer R Behrouzi, CE Barr, EJ Crosbie Cancers 13 (19), 4764, 2021 | 49 | 2021 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10320), 143-151, 2022 | 47 | 2022 |
| Pathological tau deposition in Motor Neurone Disease and frontotemporal lobar degeneration associated with TDP-43 proteinopathy R Behrouzi, X Liu, D Wu, AC Robinson, S Tanaguchi-Watanabe, ... Acta neuropathologica communications 4, 1-16, 2016 | 46 | 2016 |
| Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open … O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 401 (10387), 1499-1507, 2023 | 23 | 2023 |
| Baseline serum HE4 but not tissue HE4 expression predicts response to the levonorgestrel-releasing intrauterine system in atypical hyperplasia and early stage endometrial cancer R Behrouzi, NAJ Ryan, CE Barr, AE Derbyshire, YL Wan, Z Maskell, ... Cancers 12 (2), 276, 2020 | 22 | 2020 |
| Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet Diabetes & Endocrinology 11 (12), 905-914, 2023 | 12 | 2023 |
| Irradiation Decreases the Neuroendocrine Biomarker Pro-Opiomelanocortin in Small Cell Lung Cancer Cells In Vitro and In Vivo SL Meredith, JL Bryant, M Babur, PW Riddell, R Behrouzi, KJ Williams, ... PLoS One 11 (2), e0148404, 2016 | 12 | 2016 |
| Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised … SN Faust, R Haynes, CE Jones, N Staplin, E Whittaker, T Jaki, E Juszczak, ... The Lancet Child & Adolescent Health 8 (3), 190-200, 2024 | 6 | 2024 |
| The effects of GCSF primary prophylaxis on survival outcomes and toxicity in patients with advanced non-small cell lung cancer on first-line chemoimmunotherapy: a Sub-analysis … S Anpalakhan, P Huddar, R Behrouzi, A Signori, J Cave, C Comins, ... International Journal of Molecular Sciences 24 (2), 1746, 2023 | 5 | 2023 |
| CDK4/6 inhibitors versus weekly paclitaxel for treatment of ER+/HER2-advanced breast cancer with impending or established visceral crisis R Behrouzi, AC Armstrong, SJ Howell Breast Cancer Research and Treatment 202 (1), 83-95, 2023 | 4 | 2023 |
| Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Data Monitoring Committee of the RECOVERY ... Nature Communications 15 (1), 924, 2024 | 3 | 2024 |
| Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis S Anpalakhan, P Huddar, R Behrouzi, A Signori, J Cave, C Comins, ... Frontiers in Oncology 13, 1163768, 2023 | 3 | 2023 |
| 327P Predictors of progression-free survival in patients with metastatic breast cancer receiving palbociclib with letrozole R Behrouzi, S Moon, D Eaton Annals of Oncology 32, S507, 2021 | 1 | 2021 |
